TCL Archive New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers January 24, 1997
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions. June 2, 2006
TCL Archive ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care May 30, 2008
